Our future overview

We launched our overarching vision for the Trust in 2012 following extensive engagement with our stakeholders. It sets out a clear vision how we will transform cancer treatments and improve outcomes for patients across Greater Manchester and Cheshire.

Aligned to the Trust's vision, we developed The Christie Five Year strategic plan (2014-2019). It identifies the steps we will take to move towards this vision within the context of an underlying growth of patient numbers, an increasing patient and commissioner expectation for more local service provision and the increasing complexity and cost of specialist care, all within the anticipated environment of growing pressures on funding.

Our Annual Plan provides a robust analysis of our position, articulating the key areas of focus over the next year and is consistent with our wider strategic plans and commissioners’ strategies.

Not only do these plans ensure that the patient is at the heart of everything we do, but it demonstrates that the key service developments will be undertaken ensuring that the Trust remains operationally, clinically and financially sustainable.

To enable our team to focus upon improving the experience and outcomes of all our oncology patients, the plans not only define the investment we intend to make into facilities and expertise but also how we wish to work with the health professionals in Manchester and Cheshire to provide a more integrated, caring and personalised experience for our patients.

Related links

Our Future

Find out how we will transform cancer treatments and improve outcomes for patients.

Our developments latest news

our promise

We are leading experts in cancer care, research and education. Rated as ‘Outstanding’ by the health regulator, the Care Quality Commission, we have been pioneering cancer research breakthroughs for over 100 years and offer patients access to hundreds of clinical trials. In a global survey we have been ranked as the most technologically advanced cancer centre in the world outside North America.